轉知行政院修改「管制藥品分級及品項」部分分級及品項

各位師長、同仁和同學您好：

依據「管制藥品管理條例」第3條第2項規定，行政院於中華民國115年9月11日以院臺衛字第1151023362號公告修正「管制藥品分級及品項」部分分級及品項，並自115年9月15日起生效。茲轉知相關公告內容，敬請知悉。

本次修正重點如下：
1. 依管制藥品管理條例第3條第2項規定，公告修正「管制藥品分級及品項」部分分級及品項。
2. 修正公告自115年9月15日生效。
相關公告詳情，請參閱附件。

Announcement

Dear Faculty, Staff, and Students,

In accordance with Article 3, Paragraph 2 of the Controlled Drugs Management Act, the Executive Yuan has issued an announcement on September 11, 2026 (Document No. 1151023362) revising the classification and items of controlled drugs. This revision will take effect from September 15, 2026. Please be informed of the relevant details as follows:

Key Points of the Revision:
1. In accordance with Article 3, Paragraph 2 of the Controlled Drugs Management Act, the classification and items of controlled drugs have been revised and announced.
2. The revised announcement will come into effect on September 15, 2026.

For further details, please refer to the attached document.

Best regards,

[Taiwan Buddhist Tzu Chi University Office]